Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

33.03
Delayed Data
As of 4:00pm ET
 +0.27 / +0.82%
Today’s Change
31.90
Today|||52-Week Range
58.16
-8.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues4.8B5.1B5.7B6.5B
 
 
 
 
 
Cost of Goods Sold1.7B1.9B2.2B2.8B
 
 
 
 
 
Depreciation And Amortization305.3M314.0M587.3M331.7M
 
 
 
 
 
 
Operating ExpensesGross Income2.8B2.9B2.9B3.4B
 
 
 
 
 
General Expenses1.5B1.7B1.9B2.1B
 
 
 
 
 
Research And Development389.3M379.9M674.9M683.4M
 
 
 
 
 
Total Operating Expenses3.6B3.8B4.8B5.2B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.3B1.3B903.9M1.3B
 
 
 
 
 
Extraordinary Credit44.0M4.1M29.5M0.00
 
 
 
 
Extraordinary Charge-120.1M-964.4M-810.3M-1.5B
 
 
 
 
 
Interest Expense On Debt71.1M--178.1M480.6M
 
 
 
 
Equity In Earnings-6.0M15.2M2.0M-3.0M
 
 
 
 
 
Other Expenses-245.2M-160.1M681.0M-221.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income867.8M259.3M626.0M-913.2M
 
 
 
 
 
Income Taxes-228.2M-29.4M-210.7M-57.0M
 
 
 
 
 
Minority Interest-3.0M-12.2M-2.0M-999.2K
 
 
 
 
 
Preferred Dividend-66.1M-66.9M-65.1M-64.9M
 
 
 
 
 
Net Income636.6M257.3M419.4M-972.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS913.0M914.0M979.0M1.0B
 
 
 
 
 
Shares To Calculate EPS Diluted920.0M920.0M984.0M1.0B
 
 
 
 
 
 
Earnings Per ShareEPS$0.62$0.21$0.36-$1.11
 
 
 
 
 
EPS Diluted$0.62$0.20$0.36-$1.02